©The Author(s) 2022.
World J Hepatol. Mar 27, 2022; 14(3): 623-633
Published online Mar 27, 2022. doi: 10.4254/wjh.v14.i3.623
Published online Mar 27, 2022. doi: 10.4254/wjh.v14.i3.623
Table 5 Correlation between fibroblast growth factor 19 and alpha fetoprotein with patients’ laboratory data
| AFP | FGF-19 | |||
| r | P value | r | P value | |
| AFP | – | – | 0.383 | 0.003 |
| FGF-19 | 0.383 | 0.003 | – | – |
| Age | 0.062 | 0.640 | 0.125 | 0.343 |
| Haemoglobin | -0.196 | 0.133 | -0.060 | 0.651 |
| White blood cells | -0.064 | 0.627 | -0.144 | 0.272 |
| Platelets | 0.018 | 0.893 | -0.151 | 0.248 |
| Alanine aminotransferase | 0.036 | 0.786 | -0.151 | 0.249 |
| Aspartate aminotransferase | 0.040 | 0.764 | -0.024 | 0.855 |
| Creatinine | -0.164 | 0.211 | 0.093 | 0.480 |
| Urea | -0.022 | 0.867 | 0.012 | 0.929 |
| Albumin | -0.213 | 0.102 | -0.500 | 0.000 |
| INR | -0.001 | 0.993 | 0.357 | 0.005 |
| Bilirubin | -0.093 | 0.479 | 0.008 | 0.952 |
| Fasting blood glucose | -0.135 | 0.477 | 0.056 | 0.767 |
- Citation: Mohamed GA, Nashaat EH, Fawzy HM, ElGhandour AM. Assessment of fibroblast growth factor 19 as a non-invasive serum marker for hepatocellular carcinoma. World J Hepatol 2022; 14(3): 623-633
- URL: https://www.wjgnet.com/1948-5182/full/v14/i3/623.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i3.623